Related Experiment Video
Updated: Aug 17, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis
Maria Berndtsson1, Yoshiyuki Konishi, Azad Bonni
1Cancer Center Karolinska, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
Abstract:
Phosphorylation of BCL-2 family member BAD at different residues triggers different physiological effects, either inhibiting or promoting apoptosis. The recently identified phosphorylation site at Ser-128 enhances the apoptotic activity of BAD. We here show that BAD becomes phosphorylated at Ser-128 in the mitotic phase of the cell cycle in NIH3T3 cells. We also show that BAD-S128 is phosphorylated in taxol-treated mouse fibroblasts and MDA-MB-231 human breast cancer cells. However, expression of a phosphorylation-defective dominant negative BAD mutant did not block taxol-induced apoptosis. These data support the view that the phosphorylation of BAD Serine 128 exerts cell-specific effects on apoptosis. Whereas the BAD Serine 128 phosphorylation induces apoptosis in neuronal cells, it does not appear to promote apoptosis in proliferating non-neural cells during mitosis or upon exposure to the antineoplastic agent taxol.
Insights
Phosphorylation of BAD at Serine 128 has cell-specific effects on apoptosis. While it promotes apoptosis in neurons, it does not in proliferating non-neural cells during mitosis or taxol treatment.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The BCL-2 family member BAD regulates apoptosis through phosphorylation.
- Phosphorylation at Serine 128 (BAD-S128) was recently identified to enhance BAD's apoptotic activity.
Purpose of the Study:
- To investigate the cell-specific effects of BAD Serine 128 phosphorylation on apoptosis.
- To determine if BAD-S128 phosphorylation occurs during mitosis and in response to taxol treatment.
Main Methods:
- Western blotting to detect BAD-S128 phosphorylation in NIH3T3 cells during mitosis.
- Analysis of BAD-S128 phosphorylation in taxol-treated mouse fibroblasts and MDA-MB-231 cells.
- Utilizing a phosphorylation-defective dominant-negative BAD mutant to assess its effect on taxol-induced apoptosis.
Main Results:
- BAD becomes phosphorylated at Ser-128 during the mitotic phase in NIH3T3 cells.
- BAD-S128 phosphorylation is observed in taxol-treated mouse fibroblasts and human breast cancer cells.
- A phosphorylation-defective BAD mutant did not inhibit taxol-induced apoptosis in these cells.
Conclusions:
- BAD Serine 128 phosphorylation exhibits cell-specific roles in apoptosis regulation.
- This phosphorylation event induces apoptosis in neuronal cells but not in proliferating non-neural cells during mitosis or taxol exposure.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Drugs that Stabilize Microtubules
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade
Cellular Injury V: Apoptosis and Autophagy

